Published • loading... • Updated
Harvard Dismantles Tariff Arguments, Pharmaceutical Companies Support Trump's Plans
Summary by Deutsches Ärzteblatt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Berlin – The US Department of Commerce's investigation into allegedly discriminatory pricing of patented drugs in Germany has met with a strongly divided response. While Harvard University is dismantling the US government's arguments, the pharmaceutical industry is showing full support for the US president's approach...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
